University of Parma
Also known as: Azienda Ospedaliera-Universitaria di Parma | Azienda Ospedaliero-Universitaria di Parma | Azienda Ospedaliero-Universitaria di Parma, Parma, Italy | Azienda Ospedaliero Universitaria di Parma, University of Parma | Azienda Unità Sanitaria Locale Reggio Emilia | Department of Food and Drugs | Department of Food and Drug, University of Parma | Department of Food Science, University of Parma | Dept. of Anesthesiology and Critical Care Medicine, University of Parma, Italy | Hospital Clinica Nova | Hospital Clínica Nova | II Unit of Anesthesia, Critical Care and Pain Medicine, University Hospital of Parma, Italy | Medical Oncology Unit - University Hospital of Parma | Parma University | Section of Anesthesiology and Critical Care, Dept. of Anesthesiology, University of Parma, Italy | Section of Anesthesiology and Critical Care, Dept. of Surgical Sciences, University of Parma | Universita degli Studi di Parma | Universitaria di Parma | University Hospital of Parma: Department of Biomedical, Biotechnological and Translational Sciences, Pathological Anatomy and Histology Unit | University Hospital of Parma:Laboratory of Viral Immunopathology, Unit of Infectious Diseases and Hepatology | University Hospital of Parma:Statistica medica ed epidemiologia clinica-UO Ricerca e Innovazione | University Hospitals Parma Medical Center | University of Parma | UO II Anestesia e Rianimazione, Azienda Ospedaliero-Universitaria di Parma | UO II Anestesia, Rianimazione e Terapia Antalgica, AOU Parma | UO II Anestesia, Rianimazione e Terapia Antalgica, Azienda Ospedaliero-Universitaria di Parma | UO Nefrologia, Azienda Ospedaliero-Universitaria di Parma
Highest phase reached
Phase 4
First clinical trial
Jul 1, 1994Last known activity
Oct 31, 2023
Timeline
1330s
- Jan 1, 1332
University of Parma— Founded
Drugs by trial phase (63 distinct, 42 trials)
Phase 4 (24 own, 0 via acquisition)
Phase 3 (20 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Other trials (13 own, 0 via acquisition)
Indications
Studied for
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Cataract
- Churg-Strauss Syndrome
- Cognition Disorders
- Cognitive Dysfunction
- Coronavirus Infections
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Fibrosis
- Forearm Injuries
- Glaucoma
- Granulomatosis with Polyangiitis
- Heart Failure
- Hypertension
- Hypotension
- Lung Neoplasms
- Microscopic Polyangiitis
- Nausea
- Ocular Hypertension
- Pneumonia
- Pneumonia, Viral
- Polyarteritis Nodosa
- Postoperative Nausea and Vomiting
- Postoperative Pain
- Retroperitoneal Fibrosis
- Severe Acute Respiratory Syndrome
- Vasculitis
- Virus Diseases
- Vomiting
Recent trials (50)
- NCT06028659Lead sponsorN/AOct 31, 2023
- NCT06028659Reponsible party - principal investigatorN/AOct 31, 2023
- NCT06028659Overall official - principal investigatorN/AOct 31, 2023
- NCT05381428Lead sponsorPhase 3May 13, 2022
- NCT05662189Lead sponsorN/AMar 15, 2022
- NCT05662189Reponsible party - principal investigatorN/AMar 15, 2022
- NCT05662189OfficialN/AMar 15, 2022
- NCT05662189Sponsor investigatorN/AMar 15, 2022
- NCT05662189CollaboratorN/AMar 15, 2022
- NCT05589636Lead sponsorN/AFeb 10, 2022
- NCT05589636Reponsible party - principal investigatorN/AFeb 10, 2022
- NCT05589636CollaboratorN/AFeb 10, 2022
- NCT05220059CollaboratorN/ADec 1, 2021
- NCT06724432Lead sponsorN/AJun 1, 2021
- NCT06724432Sponsor investigatorN/AJun 1, 2021
Details
- Founded
- Parma, IT Jan 1, 1332
- Last known activity
- Oct 31, 2023